Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthias Dobbelstein

Showing results (61-70 of 108) with videos related to

Pageof 11
Sort By:
Leukemia & Lymphoma|October 27, 2006
Dysfunctional p53 deletion mutants in cell lines derived from Hodgkin's lymphomaAlexander Feuerborn, Constanze Möritz, Frederike Von Bonin, et al.
Oncotarget|April 25, 2015
5-Fluorouracil sensitizes colorectal tumor cells towards double stranded DNA breaks by interfering with homologous recombination repairUpadhyayula Sai Srinivas, Jerzy Dyczkowski, Tim Beißbarth, et al.
Plos One|April 24, 2008
NF-Y dependent epigenetic modifications discriminate between proliferating and postmitotic tissueAymone Gurtner, Paola Fuschi, Fiorenza Magi, et al.
Cell Cycle (Georgetown, Tex.)|June 2, 2023
CDK4/6 inhibition confers protection of normal gut epithelia against gemcitabine and the active metabolite of irinotecanJoshua Blume, Luisa Claus, Tamara Isermann, et al.
Journal of Virology|January 15, 2005
Enhanced cytotoxicity without internuclear spread of adenovirus upon cell fusion by measles virus glycoproteinsGerman P Horn, Sompong Vongpunsawad, Evelyn Kornmann, et al.
Nucleosides, Nucleotides & Nucleic Acids|May 14, 2024
Evaluation of N4-hydroxycytidine incorporation into nucleic acids of SARS-CoV-2-infected host cells by direct measurement with liquid chromatography-mass spectrometryKrzysztof Urbanowicz, Mikolaj Opielka, Kim M Stegmann, et al.
The Journal of Clinical Investigation|July 24, 2020
The CDK4/6-EZH2 pathway is a potential therapeutic target for psoriasisAnne Müller, Antje Dickmanns, Claudia Resch, et al.
Cell Reports|November 10, 2016
p53 Activity Results in DNA Replication Fork ProcessivityIna Klusmann, Sabrina Rodewald, Leonie Müller, et al.
Cancers|December 24, 2021
HSP90 Inhibition Synergizes with Cisplatin to Eliminate Basal-like Pancreatic Ductal Adenocarcinoma CellsKatharina M Ewers, Shilpa Patil, Waltraut Kopp, et al.
The Journal of Experimental Medicine|January 25, 2012
Inhibiting the HSP90 chaperone destabilizes macrophage migration inhibitory factor and thereby inhibits breast tumor progressionRamona Schulz, Natalia D Marchenko, Lena Holembowski, et al.
Pageof 11

Showing results (61-70 of 108) with videos related to

Sort By:
Pageof 11
Leukemia & Lymphoma|October 27, 2006
Dysfunctional p53 deletion mutants in cell lines derived from Hodgkin's lymphomaAlexander Feuerborn, Constanze Möritz, Frederike Von Bonin, et al.
Oncotarget|April 25, 2015
5-Fluorouracil sensitizes colorectal tumor cells towards double stranded DNA breaks by interfering with homologous recombination repairUpadhyayula Sai Srinivas, Jerzy Dyczkowski, Tim Beißbarth, et al.
Plos One|April 24, 2008
NF-Y dependent epigenetic modifications discriminate between proliferating and postmitotic tissueAymone Gurtner, Paola Fuschi, Fiorenza Magi, et al.
Cell Cycle (Georgetown, Tex.)|June 2, 2023
CDK4/6 inhibition confers protection of normal gut epithelia against gemcitabine and the active metabolite of irinotecanJoshua Blume, Luisa Claus, Tamara Isermann, et al.
Journal of Virology|January 15, 2005
Enhanced cytotoxicity without internuclear spread of adenovirus upon cell fusion by measles virus glycoproteinsGerman P Horn, Sompong Vongpunsawad, Evelyn Kornmann, et al.
Nucleosides, Nucleotides & Nucleic Acids|May 14, 2024
Evaluation of N4-hydroxycytidine incorporation into nucleic acids of SARS-CoV-2-infected host cells by direct measurement with liquid chromatography-mass spectrometryKrzysztof Urbanowicz, Mikolaj Opielka, Kim M Stegmann, et al.
The Journal of Clinical Investigation|July 24, 2020
The CDK4/6-EZH2 pathway is a potential therapeutic target for psoriasisAnne Müller, Antje Dickmanns, Claudia Resch, et al.
Cell Reports|November 10, 2016
p53 Activity Results in DNA Replication Fork ProcessivityIna Klusmann, Sabrina Rodewald, Leonie Müller, et al.
Cancers|December 24, 2021
HSP90 Inhibition Synergizes with Cisplatin to Eliminate Basal-like Pancreatic Ductal Adenocarcinoma CellsKatharina M Ewers, Shilpa Patil, Waltraut Kopp, et al.
The Journal of Experimental Medicine|January 25, 2012
Inhibiting the HSP90 chaperone destabilizes macrophage migration inhibitory factor and thereby inhibits breast tumor progressionRamona Schulz, Natalia D Marchenko, Lena Holembowski, et al.
Pageof 11